Vontobel Holding Ltd. Bio Techne Corp Transaction History

Vontobel Holding Ltd.

$25.5 Billion
Q1 2025

A detailed history of Vontobel Holding Ltd. transactions in Bio Techne Corp stock. As of the latest transaction made, Vontobel Holding Ltd. holds 4,960 shares of TECH stock, worth $240,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,960

Previous 5,229 5.14%

Holding current value

$240,064

Previous $376,000 22.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$58.47 - $78.75 $15,728 - $21,183	-269 Reduced 5.14%	4,960 $290,000
Q4 2024 Jan 29, 2025	SELL	$66.37 - $78.17 $296,142 - $348,794	-4,462 Reduced 46.04%	5,229 $376,000
Q3 2024 Oct 15, 2024	SELL	$70.96 - $82.35 $88,699 - $102,937	-1,250 Reduced 11.42%	9,691 $774,000
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $68,269 - $92,480	-1,099 Reduced 9.13%	10,941 $783,000
Q1 2024 May 10, 2024	SELL	$65.98 - $77.09 $274,674 - $320,925	-4,163 Reduced 25.69%	12,040 $847,000
Q4 2023 Jun 03, 2024	BUY	$52.83 - $78.22 $572,413 - $847,513	10,835 Added 403.69%	13,519 $1.04 Million
Q4 2023 Jan 29, 2024	BUY	$52.83 - $78.22 $856,004 - $1.27 Million	16,203 New	16,203 $1.25 Million
Q2 2023 Jun 03, 2024	SELL	$73.76 - $85.98 $690,098 - $804,428	-9,356 Reduced 77.71%	2,684 $219,000
Q2 2023 Jul 24, 2023	BUY	$73.76 - $85.98 $395,943 - $461,540	5,368 New	5,368 $438,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $76,431 - $105,362	-216 Reduced 25.65%	626 $277,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $93,510 - $107,637	-205 Reduced 19.58%	842 $428,000
Q3 2021 Oct 29, 2021	BUY	$444.87 - $538.88 $27,581 - $33,410	62 Added 6.29%	1,047 $507,000
Q2 2021 Aug 06, 2021	BUY	$387.35 - $450.26 $381,539 - $443,506	985 New	985 $441,000

Others Institutions Holding TECH

# of Institutions

628

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.9B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Bio Techne Corp Transaction History